Decline in cognitive function over 18 months in healthy older adults with high amyloid-β.
about
The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriersUshering in the study and treatment of preclinical Alzheimer diseaseCerebral Blood Flow and Amyloid-β Interact to Affect Memory Performance in Cognitively Normal Older Adults.An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease.Sensitivity of negative subsequent memory and task-negative effects to age and associative memory performanceBrain Amyloid Deposition and Longitudinal Cognitive Decline in Nondemented Older Subjects: Results from a Multi-Ethnic Population.Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer diseaseAlzheimer Disease Cerebrospinal Fluid Biomarkers Moderate Baseline Differences and Predict Longitudinal Change in Attentional Control and Episodic Memory Composites in the Adult Children Study.Back to the future: Alzheimer's disease heterogeneity revisited.Cognitive Impairment Precedes and Predicts Functional Impairment in Mild Alzheimer's Disease.Beta-amyloid and cognitive decline in late middle age: Findings from the Wisconsin Registry for Alzheimer's Prevention study.Cognitive impairment and decline in cognitively normal older adults with high amyloid-β: A meta-analysis.The past, present, and future of disease-modifying therapies for Alzheimer's disease.A pilot study of neuropsychological functions, APOE and amyloid imaging in patients with gliomas.Cortical β-amyloid burden, gray matter, and memory in adults at varying APOE ε4 risk for Alzheimer's disease.Diffusion Tensor Imaging Predictors of Episodic Memory Decline in Healthy Elders at Genetic Risk for Alzheimer's Disease.How technology is reshaping cognitive assessment: Lessons from the Framingham Heart Study.
P2860
Q26849380-72F9BFE1-17E4-42F4-ACBB-1D8B44288ACCQ27014791-8F3AE93C-1611-44BC-94DC-CEF4524F86B0Q33775095-6C70AB04-8ACC-4851-B11E-F8326EDA2C86Q34364368-1AAFEA8F-EEBF-4E43-AA37-039692B3BF09Q35225927-B9B2F129-0108-450F-9D2E-1546990345F5Q35722468-313EB8E5-CE74-4BC5-B7BF-F8401907BED1Q36005633-432871D8-B4F2-471A-9FE1-8E60EF551525Q36175421-1379D593-F3F3-461F-95FF-B33EC74513BAQ36785505-F194A5A4-92AF-41AC-88A4-3EA588B51DA0Q37044224-563CC208-9E2C-4651-ACCF-DAD1C6872DD5Q37100074-E46474E7-1CEA-4C67-A15F-0D1B6C3FDA06Q37650253-73383980-3D85-4DD8-8114-50FA9C597418Q46244313-D03BF400-C668-451E-95EE-67185195847CQ46352209-5C4405B5-DBAE-4689-B7F0-585562E9D462Q47716549-BAF7FA96-D78B-4573-9A5F-EB004FC5528DQ48187971-FAEBAFF4-4991-4CDD-BD60-6BF7686C9779Q48503003-E046A6CD-BF9B-4F0C-A0B7-A4A32F28D535
P2860
Decline in cognitive function over 18 months in healthy older adults with high amyloid-β.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Decline in cognitive function over 18 months in healthy older adults with high amyloid-β.
@en
Decline in cognitive function over 18 months in healthy older adults with high amyloid-β.
@nl
type
label
Decline in cognitive function over 18 months in healthy older adults with high amyloid-β.
@en
Decline in cognitive function over 18 months in healthy older adults with high amyloid-β.
@nl
prefLabel
Decline in cognitive function over 18 months in healthy older adults with high amyloid-β.
@en
Decline in cognitive function over 18 months in healthy older adults with high amyloid-β.
@nl
P2093
P50
P356
P1476
Decline in cognitive function over 18 months in healthy older adults with high amyloid-β.
@en
P2093
AIBL Research Group
Christopher C Rowe
David Ames
David Darby
Karra Harrington
Victor L Villemagne
Yen Ying Lim
P304
P356
10.3233/JAD-122170
P577
2013-01-01T00:00:00Z